Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
0.77
- 0.08 (-9.87%)
Day High: 0.85
Day Low:  0.76
Volume:    1,427,064
3:59 PM ET on Oct 23, 2017

Delayed at least 20 minutes.